192Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
Israel
Neuroscience Intelligence
Israel neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #21 of 50 · Data maturity A · Research score 39.4 · Data confidence 100.0 / 100 · Snapshot 2026-10-29 06:18 UTC.
34Recruiting trials
116Publications
42Institutions
Executive interpretation
Israel ranks #21 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. Clinical metrics and NCT evidence use only records classified as in_scope or related; out_of_scope records remain preserved outside these analytical counts. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Merck Sharp & Dohme LLC239 recruiting
Sheba Medical Center120 recruiting
Tel-Aviv Sourasky Medical Center91 recruiting
Hadassah Medical Organization80 recruiting
Rabin Medical Center70 recruiting
Shalvata Mental Health Center71 recruiting
University of Haifa61 recruiting
Rambam Health Care Campus40 recruiting
Tel Aviv University41 recruiting
NeuroDerm Ltd.40 recruiting
Disease activity
Parkinsons47trials
Adhd37trials
Autism22trials
Epilepsy12trials
Alzheimers11trials
Stroke10trials
Multiple Sclerosis9trials
Anxiety7trials
Other Neurology7trials
Neuromuscular6trials
Research institutions
Bar-Ilan UniversityOpenAlexlinked institution
Neurim Pharmaceuticals (Israel)OpenAlexlinked institution
Rappaport Family Institute for Research in the Medical SciencesOpenAlexlinked institution
Maccabi Healthcare ServicesOpenAlexlinked institution
Lander InstituteOpenAlexlinked institution
Sheba Medical CenterOpenAlexlinked institution
Israel Oceanographic and Limnological ResearchOpenAlexlinked institution
Mayanei Hayeshua Medical CenterOpenAlexlinked institution
Wolfson Medical CenterOpenAlexlinked institution
Schneider Children's Medical CenterOpenAlexlinked institution
Clinical evidence trail
NCT07771530The Efficacy of a Pharmacological Treatment (Reboxetine Plus Ritalin) Versus Dog-Assisted Therapy in PTSDRECRUITING
NCT07491874Use of Nitrous Oxide for Pain and Anxiety Management During Cervical Cerclage RemovalNOT_YET_RECRUITING
NCT07430436Improving Self-regulation in Individuals With ADHD Through Adapted Karate TrainingNOT_YET_RECRUITING
NCT07310914Implementation of an Advanced Telerehabilitation Solution for People With Multiple SclerosisNOT_YET_RECRUITING
NCT07216703A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)RECRUITING
NCT06966700A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)RECRUITING
NCT06961006A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)RECRUITING
NCT06952504A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)RECRUITING
NCT06780085A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)RECRUITING
NCT06392386A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia GravisRECRUITING
Research evidence trail
PUBMEDEffects of sleep deprivation on cognitive-motor functions and adaptive skill learning among medical residents across 26h night shifts.2027-01-01
PUBMED"The war within": psychological mediators of the relationship between cumulative stress exposure and self-reported changes in gynecological symptoms among women during wartime.2026-12-31
PUBMEDParental Concerns About their Child's Development During the First Year of Life and a Subsequent Autism Spectrum Disorder Diagnosis.2026-12-01
PUBMEDChildhood maltreatment and psychopathology during collective trauma: the longitudinal role of betrayal-related moral injury.2026-12-01
PUBMEDWar-related exposure moderates the association between attachment-related characteristics and cognitive-limbic functional connectivity in children: an fMRI study.2026-12-01
PUBMEDDoubt regarding abuse-related appraisals and identification with the aggressor as predictors of complex PTSD in female child abuse survivors.2026-12-01
PUBMEDThe Nova Protocol: a comprehensive multimodal longitudinal study among civilian survivors of a mass trauma event.2026-12-01
PUBMEDBuilding the framework for ongoing discovery: coding practice elements in child traumatic stress intervention studies.2026-12-01
PUBMEDAssociation of lifetime psychiatric history with psychological distress in women undergoing intrauterine insemination.2026-12-01
PUBMEDEffects of H-coil TMS on suicidality in major depression: A secondary analysis of data from a multisite randomized trial comparing accelerated to once-a-day stimulation.2026-12-01
PUBMEDClinical decision-making in older adults with multiple sclerosis: A National Delphi survey of Israeli MS specialists.2026-11-15
World Bank context
Macro indicators are shown only where a timestamped World Bank source row exists. Latest collection in this report: 2026-10-24 04:18 UTC. They are context, not NeuroRisk predictions.
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.